AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+1.16%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$1.73B
AUM Growth
+$1.73B
Cap. Flow
+$946K
Cap. Flow %
0.05%
Top 10 Hldgs %
45.72%
Holding
140
New
9
Increased
17
Reduced
13
Closed
14

Top Buys

1
AGEN
Agenus
AGEN
$25.2M
2
RVMD icon
Revolution Medicines
RVMD
$23.8M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$23M
4
VOR icon
Vor Biopharma
VOR
$15.5M
5
KYMR icon
Kymera Therapeutics
KYMR
$12.5M

Top Sells

1
ARGX icon
argenx
ARGX
$53M
2
SGEN
Seagen Inc. Common Stock
SGEN
$47.9M
3
BLU
BELLUS Health Inc.
BLU
$18.9M
4
SLDB icon
Solid Biosciences
SLDB
$11.2M
5
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$11M

Sector Composition

1 Healthcare 95.14%
2 Consumer Discretionary 3.86%
3 Real Estate 0.4%
4 Financials 0.24%
5 Industrials 0.19%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GRTS
51
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$6.4M 0.36% 1,856,194 +1,106,194 +147% +$3.82M
DYN icon
52
Dyne Therapeutics
DYN
$1.92B
$6.09M 0.34% 525,000 – –
ARAV
53
DELISTED
Aravive, Inc. Common Stock
ARAV
$6.04M 0.34% 4,572,515 +3,261,224 +249% +$4.31M
VERV
54
DELISTED
Verve Therapeutics
VERV
$5.81M 0.32% 300,000 -100,000 -25% -$1.94M
ALXO icon
55
ALX Oncology
ALXO
$62.7M
$5.64M 0.31% 500,000 – –
RNAC icon
56
Cartesian Therapeutics
RNAC
$261M
$5.52M 0.31% 4,883,200 – –
SYRS
57
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$5.26M 0.29% 1,463,829 – –
ETNB icon
58
89bio
ETNB
$1.34B
$5.09M 0.28% +400,000 New +$5.09M
EQRX
59
DELISTED
EQRx, Inc. Common Stock
EQRX
$4.92M 0.27% 2,000,000 -2,000,000 -50% -$4.92M
SLDB icon
60
Solid Biosciences
SLDB
$427M
$4.89M 0.27% 909,219 -2,090,781 -70% -$11.2M
AMAM
61
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
$4.89M 0.27% 2,152,291 – –
OVID icon
62
Ovid Therapeutics
OVID
$91M
$4.65M 0.26% 2,500,000 – –
AUPH icon
63
Aurinia Pharmaceuticals
AUPH
$1.58B
$4.32M 0.24% 1,000,000 – –
AURA icon
64
Aura Biosciences
AURA
$389M
$4.31M 0.24% +410,000 New +$4.31M
IMA
65
ImageneBio, Inc. Common Stock
IMA
$150M
$4.12M 0.23% 1,549,513 – –
PFTA
66
DELISTED
Perception Capital Corp. III Class A Ordinary Share
PFTA
$3.82M 0.21% 380,000 – –
NBTX
67
Nanobiotix
NBTX
$429M
$3.67M 0.2% 1,000,000 – –
IMAB
68
I-MAB
IMAB
$340M
$3.55M 0.2% 850,000 – –
ZYME icon
69
Zymeworks
ZYME
$1.12B
$3.54M 0.2% 450,000 – –
MIR icon
70
Mirion Technologies
MIR
$4.73B
$3.31M 0.18% 500,000 – –
TSHA icon
71
Taysha Gene Therapies
TSHA
$797M
$3.26M 0.18% 1,440,882 +400,000 +38% +$904K
BDTX icon
72
Black Diamond Therapeutics
BDTX
$157M
$2.96M 0.17% 1,646,517 – –
EXAI
73
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$2.93M 0.16% 550,000 – –
PRAX icon
74
Praxis Precision Medicines
PRAX
$958M
$2.86M 0.16% 1,200,000 – –
CGEM icon
75
Cullinan Oncology
CGEM
$445M
$2.64M 0.15% 250,000 – –
1 2
3
4 5